BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2022 7:25:42 AM | Browse: 512 | Download: 1247
 |
Received |
|
2021-09-04 23:53 |
|
Peer-Review Started |
|
2021-09-04 23:53 |
|
First Decision by Editorial Office Director |
|
2021-11-08 03:45 |
|
Return for Revision |
|
2021-11-08 03:45 |
|
Revised |
|
2021-11-19 18:47 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-07-08 02:52 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-07-11 19:16 |
|
Articles in Press |
|
2022-07-11 19:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-08-09 12:50 |
|
Publish the Manuscript Online |
|
2022-08-18 07:25 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ping-Tao Tseng, Mu-Hong Chen and Chih-Sung Liang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chih-Sung Liang, MD, Assistant Professor, Attending Doctor, Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, No. 60 Xinmin Road, Beitou District, Taipei 112, Taiwan. lcsyfw@gmail.com |
| Key Words |
Treatment-resistant schizophrenia; Clozapine; Clozapine-resistant schizophrenia; Ultra-resistant schizophrenia; Ultra-treatment-resistant schizophrenia; Super-refractory schizophrenia |
| Core Tip |
A diagnosis of clozapine-resistant schizophrenia (CRS) is made after administering an adequate trial of clozapine and excluding “pseudo-resistance” in patients who have been diagnosed with treatment-resistant schizophrenia (TRS). Disentangling the differences between TRS and CRS is important point for studies addressing treatment strategies for patients with CRS. |
| Publish Date |
2022-08-18 07:25 |
| Citation |
Tseng PT, Chen MH, Liang CS. Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia. World J Psychiatry 2022; 12(8): 1102-1104 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i8/1102.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i8.1102 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
